Guru Fundamental Report for CRM

Validea's guru fundamental report assigns Salesforce (CRM) a 66% rating using Partha Mohanram's P/B Growth Investor model, a score below the 80% threshold for 'some interest.' While CRM passed several key financial health metrics such as return on assets and cash flow, it failed criteria related to advertising, capital expenditures, and R&D relative to assets, indicating it does not fully align with this specific academic-backed strategy designed to identify sustained future growth in low book-to-market stocks.

Analysis

Salesforce Inc. (CRM) receives a moderate score of 66% from Validea's P/B Growth Investor model, a framework based on academic research by Partha Mohanram designed to identify high-quality growth stocks. This rating is notably below the 80% threshold that indicates strategic interest, suggesting CRM does not fully align with the model's criteria for sustained future growth. The company successfully passes several fundamental tests, including a low book-to-market ratio, positive return on assets (ROA), and strong cash flow from operations relative to assets, which also exceeds its ROA. Furthermore, CRM demonstrates stability in both ROA and sales variance, indicating a solid operational foundation. However, the model flags significant weaknesses, as the company fails criteria related to its spending levels on advertising, capital expenditures, and research and development, all measured as a percentage of assets. This mixed result portrays a company with healthy core profitability and cash generation but an investment and spending profile that diverges from what this specific model identifies as optimal for long-term growth outperformers.

Key Decisions for Investors

• Investors should view Salesforce's 66% score as a neutral-to-cautious signal from this specific growth model, as it falls short of the 80% level that would indicate a compelling buy.
• The primary red flags are the company's spending ratios; therefore, a deeper dive into its capital allocation efficiency, particularly in R&D and advertising relative to its asset base, is warranted to assess future growth potential.
• Given the conflicting signals—passing on core profitability metrics while failing on growth investment indicators—this analysis supports a hold stance rather than an aggressive buy or sell, pending further data.
• This assessment is based on a single, highly specific academic model, so investors should weigh these findings against other valuation methodologies and qualitative factors before making a final decision.